Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001902368-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
109,464
Total Value
$3,074,308.04
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Head of R&D&CMO | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 32,395 | $8.93 | $289,287.35 | 145,165 | Direct | โ | View Details | |
EVP, Head of R&D&CMO | Common Stock | โ | Sep 15, 2026 | Sale | 25,390 | $62.02 | $1,574,604.01 | 119,775 | Direct | โ | View Details | |
EVP, Head of R&D&CMO | Common Stock | โ | Sep 15, 2026 | Sale | 17,284 | $62.62 | $1,082,396.67 | 102,491 | Direct | โ | View Details | |
EVP, Head of R&D&CMO | Common Stock | โ | Sep 15, 2026 | Sale | 1,600 | $63.69 | $101,896.00 | 100,891 | Direct | โ | View Details | |
EVP, Head of R&D&CMO | Common Stock | โ | Sep 15, 2026 | Sale | 400 | $65.31 | $26,124.00 | 100,491 | Direct | โ | View Details | |
EVP, Head of R&D&CMO | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 32,395 | $0.00 | $0.00 | 43,605 | Direct | โ | View Details |